Last month, Axplora participated in CPHI Worldwide, the unmissable annual event for global players in the pharmaceutical industry.
Let’s get back to this successful CPHI Barcelona 2023 edition in video with an exclusive interview from Dr. Sylke Hassel, led by Life Sciences Knowledge Hub, to discuss the key achievements, forces and breaking news of Axplora:
- Axplora’s broad and strong network of sites, with a global footprint both in Europe and India to answer all customers’ needs and serve patients worldwide.
- The appointment of Dr. Stephan Haitz as Novasep CDMO BU President, and Dr. Pere Paton as Chief Operations Officer, to reinforce Axplora’s position as a leader in the CDMO market.
- The introduction of the newly formed Scientific Advisory Board (SAB): five industry leaders in API development and manufacturing expertise such as Flow chemistry, Electrochemistry, Steroids, Biotechnology and Antibody Drug Conjugates (ADCs).
https://www.youtube.com/watch?v=mvg1cGAnPzw&t=187s
A year after the merger between Farmabios, Novasep and PharmaZell under the single brand Axplora, CPHI was the unique opportunity to look back over our first few months as a group. A wonderful anniversary for the brand and the teams working hard behind, with promising meetings and fruitful discussions. A great outlook for the future!
Latest news
News
March 17, 2026
Biopharma’s Growing Emphasis on Highly Potent Drugs Drives Axplora Manufacturing Expansion
Highly potent drugs now account for over 30% of the global pipeline, with more than 1,000 molecules in development — Axplora’s investments in HPAPI capacity help customers bring these complex therapies to market faster $60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy New […]
News
March 17, 2026
Axplora announces multi-million-euro investment to expand lyophilization at Le Mans and appoints François Houbart as Head of Site
Axplora announces multi-million-euro investment to expand lyophilization at Le Mans and appoints François Houbart as Head of Site 18 February, 2026 – Axplora, a global CDMO Partner for complex small molecules and antibody-drug conjugates (ADCs), today announced a multi-million-euro investment to expand lyophilization (freeze-drying) capabilities at its Le Mans, France Site strengthening its ability to deliver […]
Press Release
October 08, 2025
Axplora initiates global investments exceeding €100m in 2025
Raubling, 7 October, 2025 – Axplora, a global leader in small molecule API manufacturing and a trusted partner to the world’s most innovative pharmaceutical companies, today announced that the total investments initiated across its global network in 2025 will exceed €100 million. This commitment underscores Axplora’s determination to accelerate growth, strengthen capabilities, and reinforce its […]
We enable our partners to fully realize their ambitions.
Driven by the curiosity, skills and dedication of over 2,000 employees on three continents, Axplora delivers sustainable, technologically advanced API solutions to improve lives worldwide.